
Glenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 18422.76 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 31-03-2021, the company reported a Consolidated Total Income of Rs 2868.39 Crore, up 2.37 % from last quarter Total Income of Rs 2801.85 Crore and up 2.02 % from last year same quarter Total Income of Rs 2811.63 Crore. Company reported net profit after tax of Rs 233.87 Crore in latest quarter.
Did you Know?
Stock score of Glenmark Pharmaceuticals Ltd moved up by 1 in a week.
View Latest Stock Report »Investment Rationale
A decisive breakthrough above the recent high could shift the range on the upside.
Promoter/FII Holdings
Promoters held 46.6 per cent stake in the company as of Dec 30, 2020, while FIIs held 30.2 per cent, DIIs 7 per cent and public and others 16.2 per cent.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.